Education
About Us
Working with TipRanks
Follow Us
OncoTherapy Science, Inc. (DE:30O)
FRANKFURT:30O
RESEARCH TOOLSreports
See the Price Targets and Ratings of:
30O Financial Forecast
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
€0.15→€0.16
Hold
11.95%
Upside
Reiterated
08/26/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
€0.15→€0.16
Hold
11.95%
Upside
Reiterated
08/26/25
30O Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
1
1
5
13
18
Sell
1
2
2
1
0
Strong Sell
0
0
0
0
0
total
2
3
7
14
18
Each month's total comprises the sum of three months' worth of ratings.
30O Stock Forecast FAQ
What is DE:30O’s average 12-month price target, according to analysts?
Based on analyst ratings, OncoTherapy Science, Inc.’s 12-month average price target is 0.16.
What is DE:30O’s upside potential, based on the analysts’ average price target?
OncoTherapy Science, Inc. has 14.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is OncoTherapy Science, Inc. a Buy, Sell or Hold?
OncoTherapy Science, Inc. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is OncoTherapy Science, Inc.’s share price target?
The average share price target for OncoTherapy Science, Inc. is 0.16. This is based on 0 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €0.16 ,and the lowest forecast is €0.16. The average share price target represents 14.29% Increase from the current price of €0.14.
The highest analyst share price target is €0.16 ,and the lowest forecast is €0.16. The average share price target represents 14.29% Increase from the current price of €0.14.
What do analysts say about OncoTherapy Science, Inc.?
OncoTherapy Science, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of OncoTherapy Science, Inc.?
To buy shares of DE:30O, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.